Related Experiment Videos
Development of T-cell memory against inhalant allergens: risks for the future
1Department of Cell Biology, TVW Telethon Institute for Child Health Research, West Perth, Australia.
Summary
Chronic allergic respiratory disease develops in two phases, starting in early childhood and involving immune system priming. Local immune responses in the airways determine if chronic disease develops in at-risk individuals.
Area of Science:
- Immunology
- Respiratory Medicine
- Allergy Research
Background:
- Chronic allergic respiratory diseases develop in a biphasic manner, with initial immune system priming in early life.
- This process involves the development of T-helper (Th) cell responses, which can become polarized towards Th1 or Th2 profiles.
- The second phase involves the manifestation of Th2-polarized immunity in the airways, leading to tissue damage and hyperreactivity.
Purpose of the Study:
- To explore the mechanisms underlying the development of chronic allergic respiratory disease.
- To identify factors that differentiate individuals who develop chronic disease from those who do not.
- To understand the role of local immune regulation in the airways.
Main Methods:
- Review of recent evidence on allergic respiratory disease development.
- Analysis of immune responses, including Th-cell polarization and allergen-specific immunity.
- Investigation of factors influencing local Th-cell responses in airway tissues.
Main Results:
- Allergic respiratory disease development is a two-phase process, initiated in utero and early childhood.
- While many individuals develop Th2-polarized immunity, only a subset progresses to chronic airways disease.
- This suggests that local control mechanisms in airway mucosa are critical for disease expression.
Conclusions:
- The development of chronic allergic respiratory disease is influenced by both initial immune sensitization and subsequent local regulation.
- Additional control mechanisms in airway mucosal tissues play a crucial role in determining disease outcome.
- Understanding these local regulatory mechanisms is key to managing chronic immunoinflammatory airway diseases in atopic individuals.